Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-14-118744
Filing Date
2014-03-27
Accepted
2014-03-27 17:04:07
Documents
14
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K d652763d10k.htm 10-K 760378
2 EX-4.8 d652763dex48.htm EX-4.8 7736
3 EX-10.23 d652763dex1023.htm EX-10.23 121949
4 EX-23.1 d652763dex231.htm EX-23.1 2694
5 EX-31.1 d652763dex311.htm EX-31.1 6730
6 EX-32.1 d652763dex321.htm EX-32.1 4090
13 GRAPHIC g652763g65c93.jpg GRAPHIC 51880
14 GRAPHIC g652763g77z87.jpg GRAPHIC 66743
  Complete submission text file 0001193125-14-118744.txt   5306508

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnov-20131231.xml EX-101.INS 547099
8 XBRL TAXONOMY EXTENSION SCHEMA mnov-20131231.xsd EX-101.SCH 50281
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20131231_cal.xml EX-101.CAL 65071
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20131231_def.xml EX-101.DEF 302751
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20131231_lab.xml EX-101.LAB 421681
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20131231_pre.xml EX-101.PRE 355780
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33185 | Film No.: 14722402
SIC: 2834 Pharmaceutical Preparations